| 
 
 
  
  
  
  
  
  
  
  
  
   
  
 |  | 
 
  
  
  Cod Liver Oil, the Ratio of 
  Vitamins A and D, Frequent Respiratory Tract Infections, and Vitamin D 
  Deficiency in Young Children in the United States.  Ann Otol Rhinol & 
  Laryngol 2010;119:64-70.  By Linday LA, Umhau JC, Shindledecker RD, Dolitsky JN, Holick MF. 
   
  
  This paper is a response to "Cod liver oil, vitamin A 
  toxicity, frequent respiratory infections, and the vitamin D deficiency 
  epidemic."  Ann Otol Rhinol & Laryngol 2008;117:864-70. 
   
  
  Commentary on "Breastfeeding Does 
  Not Protect Against Urinary Tract Infection in the First 3 Months of Life, but 
  Vitamin D Supplementation Increases the Risk by 76%."  Clinical 
  Pediatrics 2010;49:93-4.  By Linday LA, Shindledecker RD, Greer, FR, 
  Holick MF. 
  
  
  Dr. Linday and colleagues disagree with the way the statistics 
  were performed in the original paper, and they therefore disagree with the 
  paper's conclusion. 
   
  
  Nutritional 
  Supplements and Pediatric Upper Respiratory Tract Illnesses [letter].  J 
  Allergy Clin Immunol 2006;117:953-4.  By Linday LA. 
  
  
  Upper respiratory tract illnesses are a common cause of 
  exacerbations of asthma; Dr. Linday therefore suggests that evaluation of the 
  study dietary supplements for children with asthma is warranted.  
   
  
  Plasma 25-hydroxyvitamin D levels 
  in young children undergoing placement of tympanostomy tubes. Ann Otol Rhinol 
  Laryngol 2008;117:740-744.  
  By Linday LA, Shindledecker RD, Dolitsky JN, Chen TC, Holick MF. 
  
  ABSTRACT 
  Objective:  To report 
  plasma 25-hydroxyvitamin D [25(OH)D] levels of 16 young children undergoing 
  ambulatory surgery for placement of tympanostomy tubes.  
  Methods:  We previously 
  obtained blood samples from young children undergoing ambulatory surgery, and 
  reported that they had lower blood levels than adults of eicosapentaenoic acid 
  (an omega-3 fatty acid), vitamin A, and selenium. Plasma frozen continuously 
  at -80º was available from 16 subjects undergoing placement of tympanostomy 
  tubes.  
  Results:  Mean age = 
  3.7 years (± 1.6 SD); median = 2.9 years; range = 1.9-7.4 years. 62% were 
  male; half were white and half Hispanic; 62% were private patients; parents 
  reported half were taking vitamin supplements; none had a history of rickets. 
  None had 25(OH)D levels <10 ng/mL; 50% had 25(OH)D levels < 20 ng/mL 
  (deficient in adults); another 31% had levels from 21-29 ng/mL (insufficient 
  in adults).  
  Conclusion:  Vitamin D 
  is essential for the production of endogenous anti-microbial peptides, and has 
  been linked to seasonal, epidemic influenza A. However, the level of 25(OH)D 
  needed to prevent infection with various human pathogens has not been defined. 
  In view of increasing bacterial resistance and emerging new pathogens, further 
  research on the relationship of infection to 25(OH)D and other nutritional 
  factors is warranted. 
  
    
  
  
  
  Note:  In October 2010, Dr. 
  Linday will be an invited speaker at the American College of Nutrition (ACN) 
  51st Annual Symposium on Advances in Clinical Nutrition, to be held at the New 
  York Academy of Medicine in New York City.    
  Dr. Linday's INTERNATIONAL presentations at the Vth IAPO (Interamerican 
  Association of Pediatric Otorhinolaryngology) International Symposium on 
  Pediatric Infectious Diseases in Ear, Nose and Throat; São Paulo, Brazil, 
  October 19-21, 2007. 
   March 8, 2006: Sam Brooke Visiting Professor in Dietary Supplements at Wake 
  Forest University Medical School in Winston-Salem, North Carolina.  
  
  Dr. Linday’s chapter, "Nutritional supplements and upper 
  respiratory tract illnesses in young children living in the U.S.A.," 
  has been published in "Preventive 
  Nutrition: The Comprehensive Guide for Health Professionals, Third Edition,
  edited by A. Bendich and RJ Deckelbaum,  Humana Press Inc., 
  Totowa NJ, 2005.  
  Dr. Linday 
  wrote to the United States Department Agriculture (USDA) on December 15, 2003 
  and proposed that the supplements used in these studies be made available 
  through WIC (Special Supplemental Nutrition Program for Women, Infants, 
  and Children). Click the following link to read her letter (you will need 
  Adobe Acrobat Reader to access this information):   
  WIC Comments
  
ABSTRACTS OF  PREVIOUSLY PUBLISHED PAPERS: 
  TITLE: Effect of daily cod liver oil and a multivitamin-mineral with 
  selenium on upper respiratory tract pediatric visits by young, inner-city, 
  Latino children: Randomized pediatric sites. 
  AUTHORS: Linday LA, Shindledecker RD, Tapia-Mendoza J, Dolitsky JN 
  JOURNAL: Annals of Otology, Rhinology & Laryngology 2004, Volume 113, 
  Number 11 (November), pages 891-901  
  
  We studied the effect of daily supplementation with lemon-flavored cod 
  liver oil and a children's multivitamin-mineral supplement containing selenium 
  on the number of pediatric visits by young, inner-city, Latino children from 
  late autumn of 2002 through early spring of 2003. Two private pediatric 
  offices with similar demographics, located 1.1 miles apart in upper Manhattan, 
  New York City, were randomized to a supplementation site and a medical records 
  control site. Ninety-four children (47 at each site), 6 months to 5 years of 
  age, were enrolled. The mean age of the supplementation group was 2.03 years 
  (SD, +/- 1.04 years); that of the control group was 2.08 years (SD, +/- 1.10 
  years). Children > or = 1 year of age in the supplementation group received 1 
  teaspoon of lemon-flavored cod liver oil per day and one half-tablet of a 
  children's multivitamin-mineral; the starting dose was halved for children < 1 
  year of age. The supplements were given from enrollment through May 1, 2003. 
  The primary outcome measure was the number of upper respiratory tract 
  pediatric visits during the follow-up/supplementation period. The 
  supplementation group had a statistically significant decrease in the mean 
  number of upper respiratory tract visits over time (p = .042; r = 0.893; y = 
  0.602 - 0.002x); the medical records control group had no change in this 
  parameter (p = .999; r = 0.0006; y = 0.259 + 1.43 x 10(-6)x). The supplements 
  were well tolerated; per parental report, 70% of children completed the 5- to 
  6-month course of cod liver oil. Use of these nutritional supplements was 
  acceptable to the inner-city Latino families and their young children, and was 
  associated with a decrease in upper respiratory tract pediatric visits over 
  time; this approach therefore deserves further research and attention. 
 
Back to Top 
  TITLE: Nutritional supplements as adjunctive therapy for children with 
  chronic/recurrent sinusitis: Pilot research. 
  AUTHORS: Linday LA, Dolitsky JN, Shindledecker RD 
  JOURNAL: International Journal of Pediatric Otorhinolaryngology 2004, 
  Volume 68, Number 6 (June), pages 785-793   
  
  OBJECTIVE: Inflammation and edema of the sinonasal mucosa are important in 
  the pathophysiology of sinusitis. Based on the similarities between otitis 
  media (OM) and sinusitis, and our previous research on OM, we hypothesized 
  that nutritional supplements would be effective adjunctive therapy for the 
  treatment of children with chronic/recurrent sinusitis. METHODS: We performed 
  a 4 month, open-label, dose-titration study; subjects were enrolled from late 
  January to early March 2003. Each subject served as his own control. Study 
  supplements were a lemon-flavored cod liver oil and a children's 
  multivitamin-mineral with selenium, prescribed in escalating doses; at higher 
  doses, fish oil was substituted for cod liver oil. Subjects were private 
  pediatric otolaryngology outpatients with a clinical diagnosis of 
  chronic/recurrent sinusitis, whose symptoms were refractory to treatment with 
  antibiotics. RESULTS: Our four subjects were Caucasian males, ranging in age 
  from 4.2 to 9.8 years, with chronic/recurrent sinusitis for at least 3 years 
  prior to entry in the study. Three subjects had a positive response; one 
  subject dropped out for administrative reasons. Four, six, and eight weeks 
  after beginning study supplements, the responders had decreased sinus 
  symptoms, fewer episodes of acute sinusitis, and fewer doctor visits for acute 
  illnesses. Their parents reported that they had begun to recover from upper 
  respiratory illnesses without complications, which was unusual for these 
  children, as was improvement in springtime; their improvement had previously 
  been limited to the summer months or periods of home-schooling. CONCLUSIONS: 
  Use of flavored cod liver oil and a multivitamin-mineral with selenium as 
  adjunctive therapy for children with chronic/recurrent sinusitis is an 
  inexpensive, non-invasive intervention that clinicians can use for selected 
  patients, pending the performance of definitive, large, well-controlled 
  studies. 
Back to Top 
    TITLE: Lemon-flavored cod liver oil and a multi-vitamin/mineral 
  supplement for the secondary prevention of otitis media in young children: 
  Pilot research 
    AUTHORS: Linday LA, Dolitsky J, Shindledecker R, Pippenger CE 
    JOURNAL: Annals of Otology, Rhinology & Laryngology 2002, Volume 111, 
  Number 7 (July), pages 642-652  
  
  
  We measured blood levels of fatty acids, vitamin A, and trace metals in 
  children undergoing ambulatory surgery for placement of tympanostomy tubes and 
  a comparison group of children having other ambulatory surgical procedures; we 
  then performed a small, outpatient, secondary prevention study using 
  nutritional supplements chosen on the basis of these blood levels. Study 
  subjects had lower levels of red blood cell eicosapentaenoic acid (EPA) than 
  adult controls. Consistent with previous reports, levels of vitamin A were
   £ 40 mg/dL for 69% 
  of our subjects, and plasma selenium values for children were lower than 
  published values for adults. We then studied one otitis media (OM) season; 8 
  children (0.8 to 4.4 years of age), received one teaspoon of lemon-flavored 
  cod liver oil (containing both EPA and vitamin A) and 1/2 tablet of a 
  selenium-containing children's chewable multi-vitamin/mineral tablet, per day. 
  During this OM season, study subjects received antibiotics for OM for 12.3%
  ± 13.4 (p<0.05; mean ± 
  SD) fewer days during supplementation than before supplementation. Larger, 
  controlled trials are warranted to assess the utility of cod liver oil (of 
  acceptable purity and taste) and a children's multi-vitamin/mineral 
  preparation containing selenium, both for the prevention of OM and for the 
  acceptance of delayed prescription of antibiotics for this disorder. 
   
  
  ADDITIONAL INFORMATION: 
  
  Objectives: Part I: Measure blood levels of fatty acids, vitamin 
  A and trace metals in children undergoing ambulatory surgery for placement of 
  tympanostomy tubes (TT) and a comparison group (COMP) having other ambulatory 
  surgical procedures. Part II: Perform a small, out-patient, secondary 
  prevention study using nutritional supplements chosen on the basis of the 
  results of Part I. Study design: Part I: Perform the above blood 
  level analyses. Part II: Setting: Out-patients in a private pediatric 
  group practice. Eligibility: Children with at least one episode of otitis 
  media (OM) from 9/1 to 11/30/2000. Determine whether the daily administration 
  of one teaspoon of lemon-flavored cod liver oil and 1/2 tablet of a 
  selenium-containing children's chewable multi-vitamin/mineral preparation 
  would decrease the percentage of days antibiotics were prescribed for OM from 
  9/1/2000-3/31/2001. Results: Part I: Fatty Acids: Study 
  subjects had lower levels of red blood cell (RBC) eicosapentaenoic acid (EPA) 
  than adult controls. Mean RBC EPA values were: 1) TT=0.31% 
  ± 0.02% (SE), (n=16); 2) COMP=0.31% ± 0.04% 
  (SE), (n=5); and 3) Adult Controls=0.48% ± 0.4% 
  (SE), (n=6); (p=0.007, Kruskal-Wallis ANOVA by Ranks). Vitamin A: 
  Consistent with previous reports, levels for 69% of our subjects (27/39) were
  £ 40 m g/dL, the level 
  needed for normal dark adaptation; 15% (6/39) had sub-optimal levels (£ 
  30 m g/dL, >20 m g/dL).
  Selenium: There was no statistically significant difference between the 
  mean plasma selenium for study subjects (TT=110 ng/ml ± 
  16.3 SD; n=39) and the published values for children; children had lower 
  levels than published values for adults (p<0.005, ANOVA). Part II: 
  Eight children, 0.8-4.4 years of age, entered the secondary prevention study. 
  One could not tolerate the taste of cod liver oil; the remaining 7 children 
  received antibiotics for OM for 12.3% ± 13.4 (SD) 
  fewer days during supplementation than before (p<0.05, Wilcoxon Matched Pairs 
  Test). 5/7 subjects had no additional episodes of OM during supplementation, 
  although it had no apparent effect on established serous middle ear effusions 
  in two children. Conclusion: Larger, controlled trials are warranted to 
  assess the utility of cod liver oil (of acceptable purity and taste) and a 
  children's multi-vitamin/mineral preparation containing selenium, both for the 
  prevention of otitis media and the acceptability of delayed prescription of 
  antibiotics for this disorder. 
    
    RESEARCH REVIEW:  
    This research was reviewed and approved by the Institutional Review 
    Board of The New York Eye and Ear Infirmary. Written, informed consent was 
    obtained from at least one parent before a child entered either study; 
    assent was obtained from children over 6 years of age. 
    
    RESEARCH SUPPORT:  
    
    This work was supported in part by the Department of Otolaryngology of 
    The New York Eye and Ear Infirmary (New York, NY). MedToxÒ 
    Scientific, Inc. (St. Paul, MN) donated the vitamin and trace metal 
    analyses, performed while Dr. Pippenger (a co-author) was a consultant. J. 
    R. Carlson Laboratories, Inc. (Arlington Heights, IL) donated the 
    nutritional supplements used in the supplementation studies, but had no 
    other role in the design or conduct of the studies. 
    
  
  DISCLAIMER: 
  
  The information on this web site is provided for educational purposes only; 
  it is a general reference for healthcare consumers and providers; it is not a 
  prescription for any individual person. It is important that you consult your 
  child’s qualified healthcare provider before implementing any of the research 
  discussed on this web site. 
   
  Back 
  to Top 
  
Go to Pepcid for Autism 
Updated June 24, 2010 
 
 |